University of Michigan Rogel Cancer Center: all 322 studies

Page 2 of 4. Open to participants first (47), then studies with results posted, then the rest; newest registration first within each.

• Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic MalignanciesCompletedNCT02145403Phase 1/2Results posted
• Trial Comparing Stereotactic Body Radiation Therapy to Radiofrequency Ablation for Renal Cell CarcinomaTerminatedNCT02138578Not applicableResults posted
• Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic RadiosurgeryTerminatedNCT02097732Phase 2Results posted
• A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate CancerCompletedNCT02059213Phase 2Results posted
• Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the PancreasCompletedNCT02037230Phase 1/2Results posted
• Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck CancerCompletedNCT02031250Phase 2Results posted
• MRI Study of Changes in Blood-Brain/Tumor-Barrier Permeability in Patients With Brain Metastases During and After RadiotherapyCompletedNCT02031237Results posted
• A Pilot Study to Evaluate Neurocognitive Injury and Longitudinal Changes in White Matter During Radiation Therapy in Children With Primary Brain TumorsTerminatedNCT02006407Not applicableResults posted
• Mechanistic Study of Duloxetine in Breast Cancer Patients With Chronic PainCompletedNCT01912612Phase 2Results posted
• Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast CancerCompletedNCT01896050Results posted
• Pilot Study to Evaluate the Effect of Aromatase Inhibitor Therapy on Pain Threshold in Breast Cancer PatientsCompletedNCT01814397Results posted
• Vorinostat Plus Tacrolimus & Methotrexate to Prevent Graft vs Host Disease Following Unrelated Stem Cell TransplantCompletedNCT01790568Phase 2Results posted
• A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLLCompletedNCT01750567Phase 2Results posted
• A Pilot Study of Alpha-1-Antitrypsin (AAT) in Steroid Refractory Acute Graft vs Host DiseaseCompletedNCT01700036Phase 2Results posted
• Clinical Trial Of Neoadjuvant Chemotherapy (NAC)In Upper Tract Urothelial Carcinoma (UTUC)TerminatedNCT01663285Phase 2Results posted
• A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic CancerCompletedNCT01663272Phase 1Results posted
• Reduced-intensity Therapy for Oropharyngeal Cancer in Non-smoking HPV-16 Positive PatientsCompletedNCT01663259Not applicableResults posted
• A Trial of Gemcitabine, Infusional 5-Fluorouracil and Cisplatin for Advanced Pancreatic and Biliary CancersCompletedNCT01661114Phase 2Results posted
• A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in PatientsCompletedNCT01661088Phase 2Results posted
• A Study Using Cone Beam CT for Head and Neck CancerCompletedNCT01661062Not applicableResults posted
• Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate CancerTerminatedNCT01642732Phase 1Results posted
• Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal CancerCompletedNCT01633541Phase 2Results posted
• Evaluation of Metformin, Targeting Cancer Stem Cells for Prevention of Relapse in Gynecologic PatientsCompletedNCT01579812Phase 2Results posted
• A Study of Individualized Stereotactic Body Radiation Therapy (SBRT) for Intrahepatic CancerCompletedNCT01522937Phase 2Results posted
• Phase II Trial Evaluating Axitinib In Patients With Unresectable, Recurrent Or Metastatic Head And Neck CancerCompletedNCT01469546Phase 2Results posted
• Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 RegimenCompletedNCT01457885Phase 2Results posted
• Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to BoneTerminatedNCT01428219Phase 2Results posted
• Trial of Low-Dose Methotrexate and I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular LymphomaTerminatedNCT01389076Phase 2Results posted
• Hypofractionated Stereotactic Body Radiation Therapy (SBRT)CompletedNCT01288534Phase 2Results posted
• A Study of AT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and NeckTerminatedNCT01285635Phase 2Results posted
• Using FDG-PET During Radiation Therapy in Non-Small Cell Lung CancerCompletedNCT01190527Not applicableResults posted
• Carfilzomib and Lenalidomide With Dexamethasone Combination in Newly Diagnosed, Previously Untreated Multiple MyelomaCompletedNCT01029054Phase 1/2Results posted
• Study to Assess Effect of 8 Wks of Duloxetine Therapy on Breast Cancer Patients With Aromatase-Inhibitor Associated PainCompletedNCT01028352Not applicableResults posted
• Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial CancerTerminatedNCT00995488Phase 2Results posted
• Palonosetron for the Treatment of Nausea and Vomiting in Terminally Ill PatientsTerminatedNCT00982995Phase 2Results posted
• Study of Radiation (RT) Concurrent With Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (SCC)TerminatedNCT00904345Phase 2Results posted
• A Pilot Study Assessing Intra-Metastasis Administration of Autologous KLH-pulsed Dendritic Cells With Tumoral Radiation Therapy in Patients With Metastatic Pancreatic CarcinomaTerminatedNCT00843830Phase 1Results posted
• Phase I/II Calcitriol in Lung CancerTerminatedNCT00794547Phase 1/2Results posted
• Trial Of Double Umbilical Cord Blood TransplantationCompletedNCT00763490Phase 2Results posted
• A Phase II Study of Oral Cyclophosphamide and Sirolimus (OCR) in Advanced SarcomaCompletedNCT00743509Phase 2Results posted
• The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host DiseaseCompletedNCT00726375Phase 3Results posted
• Use of Trastuzumab to Induce Increased ER Expression in ER-negative/Low, Her-2/Neu Positive Breast CancerTerminatedNCT00726180Phase 1/2Results posted
• Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple MyelomaCompletedNCT00724568Phase 1/2Results posted
• Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial CancerCompletedNCT00645593Phase 2Results posted
• Pilot Study of dMRI as a Tool for Early Evaluation of Tumor Response in Diffuse Large B-cell LymphomaTerminatedNCT00645359Results posted
• Phase I/II Study of MK-0752 Followed by Docetaxel in Advanced or Metastatic Breast CancerCompletedNCT00645333Phase 1/2Results posted
• Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell TransplantCompletedNCT00639717Phase 2Results posted
• Blood Stem Cell Transplantation for the Treatment of Older Patients With Acute Myelogenous LeukemiaCompletedNCT00623935Phase 2Results posted
• Sunitinib Maintenance Therapy After Induction Platinum-Based Chemotherapy in Patients With ES-SCLCCompletedNCT00616109Phase 2Results posted
• Stem Cell Transplantation To Treat High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning RegimenTerminatedNCT00615589Phase 2Results posted
• Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE)TerminatedNCT00599131Phase 2Results posted
• Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic CancerCompletedNCT00593866Phase 1/2Results posted
• Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder CancerCompletedNCT00585689Phase 2Results posted
• Partial Breast Irradiation Using Accelerated Intensity Modulated RadiotherapyTerminatedNCT00581529Phase 2Results posted
• A Randomized Comparison of Radiation Therapy Techniques in the Management of Node Positive Breast CancerCompletedNCT00581256Phase 1/2Results posted
• Optimized Intensity Modulated Irradiation for Head and Neck CancerCompletedNCT00580983Not applicableResults posted
• Imatinib or Nilotinib With Pegylated Interferon-α2b in Chronic Myeloid LeukemiaTerminatedNCT00573378Phase 2Results posted
• Phase II Trial for Patients With Loco-Regional Esophageal CarcinomaTerminatedNCT00570531Phase 2Results posted
• Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan RegimenCompletedNCT00556452Phase 1/2Results posted
• Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian FailureTerminatedNCT00555477Phase 2Results posted
• Salvage Radiation Therapy and Taxotere for PSA Failure After Radical ProstatectomyTerminatedNCT00480857Phase 2Results posted
• Study of Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic CancerCompletedNCT00456599Phase 2Results posted
• Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial CarcinomaTerminatedNCT00393796Phase 2Results posted
• A Study of Mitomycin C, Irinotecan, and CetuximabTerminatedNCT00271011Phase 2Results posted
• Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue SarcomaCompletedNCT00189137Phase 2Results posted
• Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal CarcinomaCompletedNCT00176800Phase 2Results posted
• A Study of a New Combination and Schedule of Chemotherapy Drugs for the Treatment of Head and Neck CancerCompletedNCT00148122Phase 2Results posted
• Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony SarcomasCompletedNCT00148109Phase 2Results posted
• Study of Low-Intensity Conditioning for Allogeneic Stem Cell TransplantCompletedNCT00143845Phase 2Results posted
• Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis CancersCompletedNCT00141765Phase 2Results posted
• Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT)CompletedNCT00141739Phase 2Results posted
• Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell TransplantCompletedNCT00141726Phase 2Results posted
• Clinical Trial of Consolidation Treatment With Iodine I 131 Tositumomab for Multiple MyelomaCompletedNCT00135200Phase 2Results posted
• Trial Evaluating Gleevec in Patients With Anaplastic Thyroid CarcinomaTerminatedNCT00115739Phase 2Results posted
• Pilot Investigation of Dual Energy CT Imaging on an Online Adaptive Radiation Therapy SystemCompletedNCT07219134
• Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT TrialTerminatedNCT06617455Phase 2
• Pembrolizumab for the Treatment of Locally Advanced and/or Recurrent Orbital or Periocular Cutaneous Squamous Cell CarcinomaActive, not recruitingNCT06580054Phase 2
• Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly PatientsActive, not recruitingNCT06539468Not applicable
• A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive EfficacyCompletedNCT06378398Early Phase 1
• Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx CancerActive, not recruitingNCT06234748Phase 2
• Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast CancerCompletedNCT06228768Not applicable
• Effect of Pre-operative Virtual Visits on Patients With Head and Neck Cancer Undergoing SurgeryWithdrawnNCT06094621
• Intervention to Decrease Overtreatment of Patients With Low-risk Thyroid CancerCompletedNCT06073223Not applicable
• Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast CancerActive, not recruitingNCT05996107Phase 1
• Multicenter Trial of ESK981 in Patients With Select Solid TumorsActive, not recruitingNCT05988918Phase 2
• Trial of Devimistat in Combination With Modified FOLFIRINOX in Patients With Metastatic Adenocarcinoma of the PancreasWithdrawnNCT05926206Phase 1/2
• Feasibility of Virtual, Tailored, Music-Based Relaxation for Anxiety in Adolescent and Young Adult Cancer SurvivorsCompletedNCT05911269Not applicable
• Cardiac Rehabilitation to Improve Breast Cancer OutcomesTerminatedNCT05867667Not applicable
• A Proof of Concept Pilot Study of the Addition of Venetoclax to Standard Remission Induction Chemotherapy Fludarabine or Cladrabine, Cytarabine, and Granulocyte Colony Stimulating Factor (G-CSF) (FLAG or CLAG) for Frontline Therapy of Secondary Acute Myeloid LeukemiaTerminatedNCT05780879Phase 2
• Feasibility and Acceptability of Brief, Telehealth Cognitive Compensatory Training for Pediatric Cancer PatientsCompletedNCT05704790Not applicable
• Phase IV Multi-arm Study of CDK4/6 Pharmacokinetics in Healthy Volunteers With Known CYP3A4*22 GenotypeWithdrawnNCT05691400Phase 4
• Evaluating a Pharmacogenetic Testing Panel in Patients Suspected to be at Increased Risk for Pharmacogenetics-related AEs While Receiving Fluoropyrimidine or Irinotecan TherapyCompletedNCT05583422
• CLEAR Care Companion ApplicationCompletedNCT05578898Not applicable
• The Genetic Information and Family Testing (GIFT) StudyCompletedNCT05552664Not applicable
• Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I)CompletedNCT05169957Phase 1
• Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision AidCompletedNCT05140252Not applicable
• Developing a Psychosexual Educational Partners Program: PEPP A Feasibility StudyCompletedNCT05070299Not applicable
• An Attention-Restorative Therapy (ART)-Based Virtual Reality Intervention to Address Cancer-Related Cognitive Impairments Among Breast Cancer SurvivorsCompletedNCT05030792Not applicable
• Improving Quality of Life Using Patient Reported Outcomes Measures Post-operative Via Text MessagingCompletedNCT04852471Not applicable
• Pediatric-Inspired Chemotherapy Plus Tyrosine Kinase Inhibitor in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaWithdrawnNCT04845035Phase 2

← University of Michigan Rogel Cancer Center overview and focus areas